PMID- 38046183
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240108
IS  - 2752-5457 (Electronic)
IS  - 2752-5457 (Linking)
VI  - 19
IP  - 2
DP  - 2023 Jul
TI  - Alarming Surge in Early-onset Type 2 Diabetes: A Global Catastrophe on the 
      Horizon.
PG  - 7-8
LID - 10.17925/EE.2023.19.2.5 [doi]
AB  - Diabetes poses a significant threat to public health. In the last 30 years, the 
      worldwide incidence of type 2 diabetes mellitus (T2DM) has increased drastically 
      among adolescents. Since the number of young people with T2DM is rising, it is 
      anticipated that early-onset T2DM will become a common characteristic of the 
      diabetes population in developed and developing nations. Current evidence 
      suggests that beta-cell function declines more rapidly in early-onset T2DM than in 
      older-onset T2DM. In addition, early-onset T2DM appears to be associated with a 
      greater risk of complications, comorbidities and mortality than type 1 diabetes 
      mellitus. A stressful lifestyle, a shifted dietary habit and a lack of physical 
      activity are cited as causes of early-onset T2DM. Early-onset T2DM is, therefore, 
      an urgent public health concern requiring early prevention, efficient screening 
      and prompt intervention. This article discusses the recent literature on the 
      incidence, mortality, morbidity and risk variables of early-onset T2DM, and the 
      current priorities and prospective directions.
CI  - (c) Touch Medical Media 2023.
FAU - Sadat, Arefin
AU  - Sadat A
AD  - Chandpur Medical College, Chandpur, Bangladesh.
LA  - eng
PT  - Editorial
DEP - 20230713
PL  - England
TA  - touchREV Endocrinol
JT  - TouchREVIEWS in endocrinology
JID - 101779126
PMC - PMC10688561
OTO - NOTNLM
OT  - Autoimmunity
OT  - community health
OT  - insulin-dependent diabetes
OT  - preventive medicine
OT  - type 2 diabetes
OT  - youth-onset type 2 diabetes
COIS- Disclosures: Arefin Sadat has no financial or nonfinancial relationships or 
      activities to declare in relation to this article.
EDAT- 2023/12/04 06:42
MHDA- 2023/12/04 06:43
PMCR- 2023/11/01
CRDT- 2023/12/04 04:51
PHST- 2023/04/29 00:00 [received]
PHST- 2023/05/31 00:00 [accepted]
PHST- 2023/12/04 06:43 [medline]
PHST- 2023/12/04 06:42 [pubmed]
PHST- 2023/12/04 04:51 [entrez]
PHST- 2023/11/01 00:00 [pmc-release]
AID - 10.17925/EE.2023.19.2.5 [doi]
PST - ppublish
SO  - touchREV Endocrinol. 2023 Jul;19(2):7-8. doi: 10.17925/EE.2023.19.2.5. Epub 2023 
      Jul 13.